NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-508-2013-2-US-10 Inhibitors of the Farnesoid X Receptor and Uses in Medicine US National Stage 14/909,263 9540415 Issued PDF
NIAID E-257-2015-0-US-01 Compounds for Modulating FceRIB Expression and Uses Thereof US 62/289,447 Abandoned
NCI E-276-2014-0-PCT-02 Methods and Kits For Measuring and Quantifying DNA Double-Stranded Breaks Using Gamma-H2AX and H2AX PCT PCT PCT/US16/016000 Expired
NCI E-048-2010-0-US-05 Agonist/Antagonist Compositions and Methods of Use US CON 15/010,830 Abandoned
NIAID E-020-2018-0-PCT-02 CYTOMEGALOVIRUS-BASED VACCINE EXPRESSING EBOLA VIRUS GLYCOPROTEIN PCT PCT PCT/EP16/051854 Expired
NIAID E-021-2019-0-JP-05 CONFORMATIONALLY-STABILIZED RSV PREFUSION F PROTEIN JP National Stage 2016-530055 Pending
NINDS E-030-2013-0-IE-10 11-OXO-10,11-Dihydrodibenzo[B,F][1,4]Thiazepine S-Oxide Derivatives And Their Use As Dopamine D2 Receptor Antagonists IE EP 14750663.8 Issued
NINDS E-030-2013-0-BE-05 11-OXO-10,11-Dihydrodibenzo[B,F][1,4]Thiazepine S-Oxide Derivatives And Their Use As Dopamine D2 Receptor Antagonists BE EP 14750663.8 Issued
NINDS E-030-2013-0-GB-09 11-OXO-10,11-Dihydrodibenzo[B,F][1,4]Thiazepine S-Oxide Derivatives And Their Use As Dopamine D2 Receptor Antagonists GB EP 14750663.8 Issued
NINDS E-030-2013-0-CH-06 11-OXO-10,11-Dihydrodibenzo[B,F][1,4]Thiazepine S-Oxide Derivatives And Their Use As Dopamine D2 Receptor Antagonists CH EP 14750663.8 Issued
NINDS E-030-2013-0-DE-07 11-OXO-10,11-Dihydrodibenzo[B,F][1,4]Thiazepine S-Oxide Derivatives And Their Use As Dopamine D2 Receptor Antagonists DE EP 14750663.8 Issued
NINDS E-030-2013-0-FR-08 11-OXO-10,11-Dihydrodibenzo[B,F][1,4]Thiazepine S-Oxide Derivatives And Their Use As Dopamine D2 Receptor Antagonists FR EP 14750663.8 Issued
NIAID E-142-2008-0-US-05 HUMANIZED MONOCLONAL ANTIBODIES THAT SPECIFICALLY BIND AND/OR NEUTRALIZE JAPANESE ENCEPHALITIS VIRUS (JEV) AND THEIR USE US DIV 15/004,795 9783596 Abandoned PDF
NCI E-292-2014-0-PCT-02 Hydrogels and Use Thereof in Anastomosis Procedures PCT PCT PCT/US2016/014534 Expired
NCI E-292-2014-0-EP-03 Hydrogels and Use Thereof in Anastomosis Procedures EP National Stage 16703211.9 Abandoned
NCI E-171-2018-2-US-01 NON-VIRAL MODIFIED CELLS AND METHODS OF THERAPY US 62/286,206 Abandoned
E-125-2017-0-US-01 CRYSTAL STRUCTURE OF CRISPR CPF1 US 62/281,947 Abandoned
NIAID E-125-2008-0-US-05 MONOCLONAL ANTIBODIES THAT REACT WITH THE CAPSULE OF BACILLUS ANTHRACIS US DIV 15/003,719 9845350 Abandoned PDF
NIAID E-241-2014-0-JP-06 Recombinant Human/Bovine Parainfluenza Virus 3 (B/HPIV3) Expressing a Chimeric RSV/BPIV3 F Protein and Uses Thereof JP National Stage 2017-556796 Issued
NIAID E-241-2014-0-US-07 RECOMBINANT HUMAN/BOVINE PARAINFLUENZA VIRUS 3 (B/HPIV3) EXPRESSING A CHIMERIC RSV/BPIV3 F PROTEIN AND USES THEREOF US National Stage 15/545,218 10654898 Issued PDF
NIAID E-241-2014-0-PCT-02 Recombinant Human/Bovine Parainfluenza Virus 3 (B/HPIV3) Expressing a Chimeric RSV/BPIV3 F Protein and Uses Thereof PCT PCT PCT/US2016/014154 Expired
NIAID E-241-2014-0-CN-04 Recombinant Human/Bovine Parainfluenza Virus 3 (B/HPIV3) Expressing a Chimeric RSV/BPIV3 F Protein and Uses Thereof CN National Stage 201680012795.5 Pending
NIAID E-241-2014-0-EP-05 Recombinant Human/Bovine Parainfluenza Virus 3 (B/HPIV3) Expressing a Chimeric RSV/BPIV3 F Protein and Uses Thereof EP National Stage 16702318.3 Pending
NIAID E-241-2014-0-CA-03 Recombinant Human/Bovine Parainfluenza Virus 3 (B/HPIV3) Expressing a Chimeric RSV/BPIV3 F Protein and Uses Thereof CA National Stage 2974359 Pending
NCI E-089-2016-0-US-01 Niclosamide Therapy For Adrenal Cancer US 62/280,521 Abandoned
NCATS E-026-2016-0-AR-02 Compounds for Improving mRNA Splicing AR ORD P160100117 Pending
NCATS E-026-2016-0-VE-05 Compounds for Improving mRNA Splicing VE ORD 2016000024 Abandoned
NCATS E-026-2016-0-CL-12 Compounds for Improving MRNA Splicing CL National Stage 2017-01823 Issued
NCATS E-026-2016-0-CA-17 Compounds for Improving MRNA Splicing CA National Stage 2973949 Issued
NCATS E-026-2016-0-EP-06 Compounds for Improving MRNA Splicing EP National Stage 16737944.5 Issued
NCATS E-026-2016-0-GR-01 Compounds for Improving MRNA Splicing GR EP 16737944.5 Issued
NCATS E-026-2016-0-HU-01 Compounds for Improving MRNA Splicing HU EP 16737944.5 Issued
NCATS E-026-2016-0-IT-01 Compounds for Improving MRNA Splicing IT EP 16737944.5 Issued
NCATS E-026-2016-0-IE-01 Compounds for Improving MRNA Splicing IE EP 16737944.5 Issued
NCATS E-026-2016-0-SE-01 Compounds for Improving MRNA Splicing SE EP 16737944.5 Issued
NCATS E-026-2016-0-PL-01 Compounds for Improving MRNA Splicing PL EP 16737944.5 Issued
NCATS E-026-2016-0-RO-01 Compounds for Improving MRNA Splicing RO EP 16737944.5 Issued
NCATS E-026-2016-0-NO-01 Compounds for Improving MRNA Splicing NO EP 16737944.5 Issued
NCATS E-026-2016-0-SK-01 Compounds for Improving MRNA Splicing SK EP 16737944.5 Issued
NCATS E-026-2016-0-PT-01 Compounds for Improving MRNA Splicing PT EP 16737944.5 Issued
NCATS E-026-2016-0-SI-01 Compounds for Improving MRNA Splicing SI EP 16737944.5 Issued
NCATS E-026-2016-0-ES-01 Compounds for Improving MRNA Splicing ES EP 16737944.5 Issued
NCATS E-026-2016-0-DE-01 Compounds for Improving MRNA Splicing DE EP 16737944.5 Issued
NCATS E-026-2016-0-FR-01 Compounds for Improving MRNA Splicing FR EP 16737944.5 Issued
NCATS E-026-2016-0-FI-01 Compounds for Improving MRNA Splicing FI EP 16737944.5 Issued
NCATS E-026-2016-0-CZ-01 Compounds for Improving MRNA Splicing CZ EP 16737944.5 Issued
NCATS E-026-2016-0-DK-01 Compounds for Improving MRNA Splicing DK EP 16737944.5 Issued
NCATS E-026-2016-0-BE-01 Compounds for Improving MRNA Splicing BE EP 16737944.5 Issued
NCATS E-026-2016-0-AT-01 Compounds for Improving MRNA Splicing AT EP 16737944.5 Issued
NCATS E-026-2016-0-CH-01 Compounds for Improving MRNA Splicing CH EP 16737944.5 Issued